AIM ImmunoTech Inc.

Research AIM ImmunoTech Inc. (0A4Y) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

• Ticker0A4Y
• ExchangeLSE
• CountryUnited States
• CurrencyUSD

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome;

Frequently asked questions

What does AIM ImmunoTech Inc. do?

AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.